DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Hematologic Disorder

Hereditary Elliptocytosis

LOW SEVERITY

Inherited blood disorder characterized by oval or elliptical red blood cells. Usually autosomal dominant inheritance. Most common in people of African or Mediterranean descent. Spectrum from asymptomatic carriers to severe hemolytic anemia.

Global Affected

200.0K

Countries

15

Symptoms

Usually asymptomatic
Mild anemia
Splenomegaly
Jaundice
Gallstones
Fatigue (severe cases)

Treatment Options

Folic acid supplementation
Observation (asymptomatic)
Splenectomy (severe cases)
Phototherapy (neonatal jaundice)
Blood transfusions (rare)

Risk Factors

1Family history
2African ancestry
3Mediterranean ancestry
4Southeast Asian ancestry

Diagnostic Methods

  • 1Peripheral blood smear
  • 2Osmotic fragility test
  • 3Eosin-5-maleimide (EMA) binding test
  • 4Genetic testing
  • 5Complete blood count

Prognosis

Excellent for most patients. 90% are asymptomatic and have normal life expectancy. Those with compensated hemolysis may have mild anemia but normal activity levels. Severe cases (hereditary pyropoikilocytosis) may require splenectomy with good outcomes. Neonatal period may have severe hemolysis requiring phototherapy.

Prevention

  • Genetic counseling
  • Family screening
  • Prenatal diagnosis (severe variants)

Research Status

Most patients require no treatment. Folic acid supplementation for those with hemolysis. Splenectomy reserved for severe cases with significant anemia. Newborn screening helps identify severe variants early.

Sources

  • https://www.ncbi.nlm.nih.gov/books/NBK1116
  • https://www.hematology.org
  • https://rarediseases.org

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.